EYPT - Company ID 0001314102
The table below shows EyePoint Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $101.82M | $99.70M | $281.26M | $95.63M | $178.59M | $44.91M |
| Short-term investments | $204.26M | $271.21M | $49.79M | $48.93M | $32.97M | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $1.81M | $2.31M | $3.91M | $2.89M | $3.62M | $5.34M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $328.65M |
| $383.31M |
| $344.80M |
| $172.81M |
| $237.75M |
| $63.12M |
| Property, plant & equipment | $9.02M | $8.18M | $5.25M | $1.36M | $476.00K | $630.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $364.00M | $418.46M | $355.18M | $180.36M | $263.37M | $91.72M |
| Accounts payable | $10.49M | $11.72M | $6.50M | $5.92M | $7.38M | $4.81M |
| Total current liabilities | $37.02M | $49.05M | $63.26M | $34.54M | $23.66M | $14.89M |
| Long-term debt | - | - | $29.31M | $29.31M | $36.56M | $37.98M |
| Total liabilities | $57.88M | $81.96M | $88.86M | $83.99M | $78.99M | $73.18M |
| Retained earnings | -$1.10B | -$873.02M | -$742.15M | -$671.35M | -$569.10M | -$510.68M |
| Total equity | $306.11M | $336.50M | $266.32M | $96.37M | $184.38M | $18.54M |